6 results match your criteria: "Cancer Institute of New South Wales[Affiliation]"
Assessing the Quality and Behavior Change Potential of Vaping Cessation Apps: Systematic Search and Assessment.
JMIR Mhealth Uhealth
March 2024
Instutite for Health Transformation, Faculty of Health, Deakin University, Geelong, Victoria, Australia.
Background: An increasing number of people are using vapes (e-cigarettes), and with growing evidence of associated harms, there is a need for acceptable cessation support and interventions. Smartphone apps for health and well-being have increased in popularity and use. Limited published literature assesses the potential of apps to support vaping cessation.
View Article and Find Full Text PDFThe effect of general practice contact on cancer stage at diagnosis in Aboriginal and non-Aboriginal residents of New South Wales.
Cancer Causes Control
October 2023
Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, Australia.
Purpose: Older age, risks from pre-existing health conditions and socio-economic disadvantage are negatively related to the prospects of an early-stage cancer diagnosis. With older Aboriginal Australians having an elevated prevalence of these underlying factors, this study examines the potential for the mitigating effects of more frequent contact with general practitioners (GPs) in ensuring local-stage at diagnosis.
Methods: We compared the odds of local vs.
The Effect of Methylphenidate on Fatigue in Advanced Cancer: An Aggregated N-of-1 Trial.
J Pain Symptom Manage
September 2015
Cancer Institute of New South Wales, Sydney, New South Wales, Australia; Department of Palliative and Supportive Care, Flinders University, Adelaide, South Australia, Australia.
Context: Fatigue is common in life-limiting cancer. Methylphenidate (MPH), a psychostimulant, may be a useful therapy. Gathering evidence in patients with advanced cancer can be challenging.
View Article and Find Full Text PDFDevelopment and evaluation of information resources for patients, families, and healthcare providers addressing behavioral and cognitive sequelae among adults with a primary brain tumor.
J Neurosci Nurs
June 2015
Questions or comments about this article may be directed to Kylie M. Wright, MN BN RN, at She is a Clinical Nurse Consultant, Liverpool Hospital, and New South Wales Oncology Group, Neuro-oncology, Cancer Institute of New South Wales, Sydney, Australia. Grahame K. Simpson, PhD MAASW MAPS, is a Senior Social Worker-Clinical Specialist, and Associate Professor/Group Leader of the Brain Injury Rehabilitation Research Group, Ingham Institute of Applied Medical Research, Liverpool Hospital, Sydney, Australia. Eng-Siew Koh, MBBS FRANZCR, is a Staff Specialist in Radiation Oncology, New South Wales Oncology Group, Neuro-oncology, Cancer Institute of New South Wales; Collaboration for Cancer Outcomes Research and Evaluation, Liverpool Hospital, University of New South Wales; and Liverpool Cancer Therapy Centre, Liverpool Hospital, Sydney, Australia. Diane L. Whiting, BA(Hons) M Psychol(Clinical), is a Senior Clinical Psychologist, Liverpool Brain Injury Rehabilitation Unit, Liverpool Hospital, Sydney, Australia. Lauren Gillett, BA Psy(Hons) DPsy, is a Clinical Psychologist, Brain Injury Rehabilitation Research Group, Ingham Institute of Applied Medical Research, Sydney, Australia. Teresa Simpson, MC BSW RN, is a Senior Social Worker, New South Wales Oncology Group, Neuro-oncology, Cancer Institute of New South Wales, and Liverpool Cancer Therapy Centre, Liverpool Hospital, Sydney, Australia. Rochelle Firth, MN BN RN, is a Nurse Practitioner, Department of Neurosurgery Royal North Shore Hospital, and New South Wales Oncology Group, Neuro-oncology, Cancer Institute of New South Wales, Sydney, Australia.
Behavioral and cognitive changes in patients with primary brain tumor (PBT) are common and may be distressing to patients and their family members. Healthcare professionals report a strong need for information, practical strategies, and training to assist consumers and better address management issues. A literature review by the current project found that 53% of the information resources currently available to consumers and health professionals contained minimal or no information about cognitive/behavioral changes after PBT, and 71% of the resources contained minimal or no information on associated strategies to manage these changes.
View Article and Find Full Text PDFThe role of primary care in early detection and follow-up of cancer.
Nat Rev Clin Oncol
January 2014
Sydney School of Public Health, Edward Ford Building (A27), University of Sydney, Sydney, New South Wales 2006, Australia.
Primary care providers have important roles across the cancer continuum, from encouraging screening and accurate diagnosis to providing care during and after treatment for both the cancer and any comorbid conditions. Evidence shows that higher cancer screening participation rates are associated with greater involvement of primary care. Primary care providers are pivotal in reducing diagnostic delay, particularly in health systems that have long waiting times for outpatient diagnostic services.
View Article and Find Full Text PDFPsychosocial impact of cutaneous toxicities associated with epidermal growth factor receptor-inhibitor treatment.
Clin J Oncol Nurs
February 2011
Cancer Institute of New South Wales, Sydney Nursing School, University of Sydney, Australia.
Epidermal growth factor receptor inhibitors (EGFRIs) are an increasingly important class of anticancer agents. Cutaneous toxicities, the most common adverse effects of EGFRI therapy, require dose modification or treatment cessation when moderate or severe and may compromise treatment compliance. To date, assessment has focused on physical symptoms associated with cutaneous toxicities; however, the psychosocial impact of those effects requires greater consideration.
View Article and Find Full Text PDF